Tim Babinchak

Tim Babinchak

UNVERIFIED PROFILE

Are you Tim Babinchak?   Register this Author

Register author
Tim Babinchak

Tim Babinchak

Publications by authors named "Tim Babinchak"

Are you Tim Babinchak?   Register this Author

7Publications

79Reads

6Profile Views

Safety and Clinical Outcomes of an Equine-Derived Heptavalent Botulinum Antitoxin Treatment for Confirmed or Suspected Botulism in the United States.

Clin Infect Dis 2019 Jun 15. Epub 2019 Jun 15.

Medical Affairs Department, Emergent BioSolutions Incorporated, Gaithersburg, United States of America.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cid/ciz515DOI Listing
June 2019

Comparative treatment-related adverse event cost burden in immune thrombocytopenic purpura.

J Med Econ 2017 Nov 8;20(11):1200-1206. Epub 2017 Sep 8.

b IMS Health , San Francisco , CA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/13696998.2017.1370425DOI Listing
November 2017

Trends in susceptibility of selected gram-negative bacilli isolated from intra-abdominal infections in North America: SMART 2005-2010.

Diagn Microbiol Infect Dis 2013 Jul 27;76(3):379-81. Epub 2013 Mar 27.

International Health Management Associates, Inc., Schaumburg, IL 60173, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.diagmicrobio.2013.02.031DOI Listing
July 2013

Rising incidence of Staphylococcus aureus with reduced susceptibility to vancomycin and susceptibility to antibiotics: a global analysis 2004-2009.

Int J Antimicrob Agents 2011 Mar 15;37(3):219-24. Epub 2011 Jan 15.

IHMA Europe Sàrl, 4 Route de la Corniche, 1066 Epalinges, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijantimicag.2010.10.029DOI Listing
March 2011